1Chandra P, Chaudhery SA, Rosener F, et al. Transient histocytosis with striking phagocytosis of platelets, leukocytes and erythrocytes. Arch Intern Med, 1975; 135:989 -991
2Janka G, Zur Stadt U. Familial and acquired hemophagocytic lym- phohistiocytosis. Hematology Am Soc Hematol Educ Program, 2005 : 82 - 88
4Henter JI, Home AC, Arico M, et al. HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis, Pediatr Blood Cancer 2007 ;48:124 - 131
6Evans DL, Pedersen CA, Folds JD. Major depression and immunity : preliminary evidence of decreased natural killer cell populations. Prog Neuropsychopharmacol Biol Psychiatry. 1988 ; 12:739 -748
7Kontopoulou T, Tsaousis G, Vaidakis E , et al . Hemophagocytic syndrome in association with visceral leishmaniasisJ. Am J Med, 2002; 113:439-440
8Eguchi K. Systemic lupus erythematosus complicated by cytomegalo- virus- induced hemophagocytic syndrome and colitis. Intern Med, 2002; 41:77 -78
9Bielekova B, Catalfamo M, Reichert-Scrivner S, et al. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci USA, 2006; 103:5941 -5946
10Koizumi K, Haseyama Y, Machino R, et al. The hemophagocytic syndrome in prostate cancer revealed by disseminated carcinomatosis of the bone marrow. J Uro, 2002; 168:1101 -1102
1Chen RL, Su IJ,Lin KH, et al.Fulminant childhood hemophagocytic syndrome mimicking histiocytic medullaryreticulosis :an atypical form of EBV infection [J]. Am J Clin Pathol, 1991,96(2): 171-176.
2HenterJ, Samuetsson A, Ericson K, et al. Familial hemophago- cytic lymphohistiocytosis:diagnosis,treatment and pathophy- siological mechanisms [J]. Laartidningen, 2000,97 (12) : 1405-1408.
3Wilson MS,Welss LM , Gatter KC, et al.Malignant histio- cytosis:a reassesment of cases previously in 1975 based on paraffin section im munophenotyping studies[J].Cancer, 1990,66(3) : 530-536.
4Kurzrock R. Therapy of T cell lymphomas with pentostatin [J]. Ann N Y Acad Sci,2001,941:200-205.
5Tsimberidou AM, Giles F, Duvic M, et al. Phase 11 study of pentostatin in advanced T-cell lymphoid malig- nancies: update of an M.D. Anderson Cancer Center series [J1. Cancer.2004.100( 1 ):342-349.
